baber/WOPTO huggingface dataset:
Patent AT-E345693-T1 (AT)
Inventor: EGER SHAUL
IPC: A23D7/00
Filed: 2000-01-03
Granted: 2006-12-15
Abstract: The present invention is of a food spread containing a mixture of at least one non-hydrogenated edible oil of natural or synthetic origin and a monoglyceride. Moreover, the spread of the present invention does not contain an aqueous phase. The oil is preferably one or more of the oils from the group of olive oil, avocado oil, canola oil, soybean oil, sunflower oil, nut oils, walnut oil, peanut oil, safflower oil, cottonseed oil, coconut oil, rice bran oil, mustardseed oil, camelina oil, chia oil, flaxseed oil, perilla oil, fish oil, palm oil, sesame oil, wheatgerm oil, jojoba oil or corn oil. More preferably an oil such as avocado oil, fish oil, palm oil or olive oil is used and most preferably the oil is olive oil and fish oil. The monoglycerides used are preferably derivatives of oleic, or palmitic acid. The oil is present preferably in an amount of from about 85 to about 98 percent and most preferably in an amount of from about 93 to about 96 percent. The more monoglyceride used, the greater the degree of solidity of the food spread at room temperature. It is therefore possible to produce a desired degree of solidity, by changing the proportion of monoglyceride.
Patent AT-E287927-T1 (AT)
Inventor: SMITH JEANINE A
IPC: C08J5/00
Filed: 1999-12-08
Granted: 2005-02-15
Abstract: A polymer composition with improved scratch and mar resistance contains (1) a graft copolymer comprising a backbone of a propylene polymer material having graft polymerized thereto at least one vinyl monomer capable of being polymerized by free radicals, and (2) an additive selected from the group consisting of (a) about 0.5% to about 10% of at least one low molecular weight ethylene polymer or a functionalized derivative thereof, and (b) a combination of (i) about 0.5% to about 10% of at least one of the low molecular weight ethylene polymers in (a) and (ii) about 0.5% to about 10% of inorganic microspheres, based on the total weight of the composition. Optionally the composition can also contain a compatibilizing agent such as an unsaturated carboxylic acid-functionalized propylene polymer material. The composition can optionally contain about 2% to about 30% of one or more rubber components, about 15% to about 50% of a broad molecular weight distribution propylene polymer material, or a combination of the two.
Patent AT-E258195-T1 (AT)
Inventor: MALM BO
IPC: C08F8/50
Filed: 1999-11-12
Granted: 2004-02-15
Abstract: Polypropylene heterophasic copolymers with good flow and impact properties are made by visbreaking a starting polypropylene heterophasic copolymer of which the amorphous rubber has an intrinsic viscosity of 2 dl/g or more and the ethylene content in the amorphous rubber, determined as C2 of AM, is from 20 wt-% to 45 wt-%.
Patent DE-03781469-T1 (DE)
Inventor: MILLER J
IPC: A61F13/00
Filed: 2003-10-29
Abstract: Silicone adhesive formulations are provided, in which fentanyl particles are suspended one or more a solvated silicone adhesives. The formulations can be used for manufacturing improved, matrix-type transdermal devices for administering fentanyl.
Patent DE-17821718-T1 (DE)
Title: Zusammensetzungen zur verbesserung der gehirnaktivität
Inventor: PEREZ-MACHIN Ruben
IPC: A61P25/26
Filed: 2017-07-19
Abstract: Zusammensetzung umfassend:a) eine wirksame Menge eines Extrakts aus Cyperus esculentus-Schale, Cyperus esculentus-Rhizomen oder einer Kombination davon; undb) eine wirksame Menge an Mangiferin, Norathyriol oder einen Extrakt, der Mangiferin oder Norathyriol umfasst, wobei der Extrakt, der Mangiferin oder Norathyriol umfasst, ein Mangiferin enthaltender Extrakt aus einer Pflanzenart einer Gattung ist, die ausgewählt ist aus der Gruppe bestehend aus Mangifera, Salacia, Cyclopia, Hypericum, Canscora, Fagraea, Gentiana, Hoppea, Swertia, Hypericum, Polygala, Ziziphus und Gemischen davon, wobei das Verhältnis von (a) zu (b) zwischen 1:1 und 50:1 ist.
Patent DE-314155-T1 (DE)
Inventor: BAUER GEORGE W
IPC: H02J7/00
Filed: 1988-10-28
Abstract: A system for sequentially charging a plurality of batteries initially interrogates each battery to determine the battery type and the level of charge. The charging system prioritizes the batteries to be charged from most to least fully charged and charges the batteries in that order. The charging is provided by pulsed current during sequential portions of periodic intervals to charge the batteries in a short period of time and utilize the battery charger to full or nearly full capacity.
Patent ES-2117614-T1 (ES)
Inventor: MEHROTRA PANKAJ KUMAR
IPC: B23P13/00
Filed: 1994-03-31
Abstract: A densified titanium diboride based ceramic composition metal cutting tool is provided having W and Co therein and a fine grain size. The metal cutting tool has particular usefulness for the machining of titanium based alloys at high speeds.
Patent CY-1108240-T1 (CY)
Inventor: NICOLAS JEAN-FRANÇOIS
IPC: C12N1/15
Filed: 2008-08-06
Abstract: The present invention is concerned with modified polynucleotides derived from a native gene and having a reduced or increased number of epigenetic control motifs, at the nucleotide level, as compared to the native gene. These polynucleotides are useful to study, increase and/or reduce genes expression, and to improve DNA vaccination methods. The present invention also relates to methods of using these modified polynucleotides in  in vitro  and  in vivo  expression systems.
Patent CY-1110434-T1 (CY)
Title: Παραγωγα ν-πυρρολιδιν-3-υλ-αμιδιου ως αναστολεις επαναπροσληψεως σεροτονινης και νοραδρεναλινης
Inventor: FISH PAUL VINCENT
IPC: C07D207/14
Filed: 2008-08-14
Abstract: Μία ένωση του Τύπου (I) και φαρμακευτικά και/ή κτηνιατρικά αποδεκτά παράγωγα της, όπου το R1 είναι Η, C1-6αλκύλιο, -C(X)Y, C3-8κυκλοαλκύλιο, αρύλιο, ετεροκυκλική ομάδα, άρυλο-C1-4 αλκύλιο ή ετερόκυκλο-C1-4αλκύλιο, όπου οι κυκλο-αλκυλικές, αρυλικές ή ετεροκυκλικές ομάδες είναι προαιρετικά υποκατεστημένες με τουλάχιστον έναν υποκατάστατη που επιλέγεται ανεξάρτητα από τους C1-8αλκύλιο, C1-8αλκοξύλιο, ΟΗ, αλογονο-ομάδα, CF3, OCF3, SCF3, υδρόξυ-C1-6αλκύλιο, C1-4αλκόξυ-C1-6αλκύλιο και C1-4αλκύλιο-S-C1-4αλκύλιο. To R2 είναι αρύλιο ή ετεροαρύλιο το καθένα από τα οποία είναι προαιρετικά υποκατεστημένο με τουλάχιστον έναν υποκατάστατη που επιλέγεται ανεξάρτητα από τους C1-8αλκύλιο, C1-8αλκοξύλιο, ΟΗ, αλογονο-ομάδα, CF3, OCF3, SCF3, υδρόξυ-C1-6αλκύλιο, C1-4αλκόξυ-C1-6αλκύλιο και C1-4αλκύλιο-S-C1-4αλκύλιο. To R3 είναι C1-6αλκύλιο, C3-8κύκλοαλκύλιο, C3-8κύκλοαλκύλιο-C1-6αλκύλιο, αρύλιο, ετεροκυκλική ομάδα, άρυλο-C1-4αλκύλιο ή ετερόκυκλο-C1-4αλκύλιο, όπου οι κυκλοαλκυλικές, αρυλικές ή ετεροκυκλικές ομάδες είναι προαιρετικά υποκατεστημένες με τουλάχιστον έναν υποκατάστατη που επιλέγεται ανεξάρτητα από τους C1-6αλκύλιο, C1-6αλκοξύλιο, ΟΗ, αλογονο-ομάδα, CF3, OCF3, SCF3, υδρόξυ-C1-6αλκύλιο, C1-4αλκόξυ-C1-6αλκύλιο και C1-4αλκύλιο-S-C1-4αλκύλιο. To Χ είναι S ή Ο. Το Υ είναι Η, C1-6αλκύλιο, αρύλιο, ετεροκυκλική ομάδα, άρυλο-C1-4αλκύλιο ή ετερόκυκλο –C1-4αλκύλιο. Και το n είναι 1 ή 2, υπό την προϋπόθεση ότι όταν το n είναι 1, το m είναι 0 ή 1, και όταν το n είναι 2, το m είναι 0, όπου όταν το m είναι 0 τότε το * απεικονίζει ένα χειρόμορφο κέντρο. Οι ενώσεις της εφευρέσεως επιδεικνύουν δραστικότητα ως αναστολείς επαναπροσλήψεως τόσο της σεροτονίνης όσο και της νοραδρεναλίνης και επομένως έχουν χρησιμότητα σε μία ποικιλία θεραπευτικών πεδίων, όπως για παράδειγμα η ακράτεια ούρων.
Patent CY-1112520-T1 (CY)
Title: Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
Inventor: BERGER MARKUS
IPC: C07D405/14
Filed: 2012-02-28
Abstract: Η παρούσα εφεύρεση αναφέρεται σε ενώσεις του τύπου Ι, διαδικασίες για την παραγωγή τους και τη χρήση τους ως αντι-φλεγμονώδεις παράγοντες.
Patent CY-1113174-T1 (CY)
Title: Στελεχη ζυμων που παραγουν χοληστερολη και οι εφαρμογες τους
Inventor: POMPON DENIS
IPC: C12P33/00
Filed: 2012-10-04
Abstract: Η παρούσα εφεύρεση αφορά την παραγωγή χοληστερόλης στους οργανισμούς του βασιλείου των μυκήτων (Fungi). Πιο δυγκεκριμένα, η εφεύρεση αφορά τους γενετικά τροποποιημένους μύκητες οι οποίοι παράγουν αυτόνομα χοληστερόλη από μια πηγή απλού άνθρακα. Η εφεύρεση αφορά επίσης τη χρήση μυκήτων σύμφωνα με την εφεύρεση για την παραγωγή μη ιχνηθετημένης και ιχνηθετημένης χοληστερόλης.
Patent CY-1116976-T1 (CY)
Title: Κρυσταλλικο 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-δioξo-3,4-δiϋδpοπυριmiδιν-1-(2η)-υλ)-4-φθορο-3-υδροξυ-4-μεθυλτετραϋδροφουραν-2-υλ)μεθοξυ)(φαινοξυ)φωσφορυλ)αμινο)προπανοϊκο (s)-ισοπροπυλιο
Inventor: ROSS BRUCE S
IPC: A61K31/7072
Filed: 2015-11-24
Abstract: Αποκαλύπτονται εις το παρόν φωσφοραμιδικά νουκλεοζιδίων και η χρήση αυτών ως παράγοντες για αγωγή ιικών παθήσεων. Αυτές οι ενώσεις είναι αναστολείς της εξαρτώμενης από RNA ιικής αντιγραφής RNA και είναι χρήσιμες ως αναστολείς της πολυμεράσης του NS5B του HCV, ως αναστολείς της αντιγραφής του HCV και για την αγωγή της λοίμωξης από ηπατίτιδα C σε θηλαστικά.
Patent CY-1123312-T1 (CY)
Title: Aav-βασιζομενη γονιδιακη θεραπεια για σκληρυνση κατα πλακας
Inventor: HOFFMAN BRAD E
IPC: A01N63/00
Filed: 2020-09-02
Abstract: Αποκαλυπτόμενες είναι AAV ιικά-βασιζόμενες συνθέσεις φορέα χρήσιμες στην απελευθέρωση ποικιλίας τμημάτων νουκλεϊνικού οξέος, που συμπεριλαμβάνουν αυτά που κωδικοποιούν θεραπευτικά πολυπεπτίδια προς επιλεγέντα κύτταρα ξενιστές θηλαστικού για χρήση σε θεραπευτικές αυτοάνοσες μορφές, που συμπεριλαμβάνουν, για παράδειγμα, την in vivo διέγερση ανοσολογικής ανοχής μέσω μιας κατευθυνόμενης στο ήπαρ AAV-βασιζόμενης γονιδιακής θεραπευτικής αγωγής για θεραπεία ή/και βελτίωση αυτοάνοσων διαταραχών όπως σκλήρυνσης κατά πλάκας.
Patent CY-1124979-T1 (CY)
Title: Κατασκευασματα πρωτεϊνης uspa2 και χρησεις αυτων
Inventor: CASTADO CINDY
IPC: A61K39/00
Filed: 2021-11-30
Abstract: Η παρούσα εφεύρεση αφορά σε συνθέσεις που περιλαμβάνουν Moraxella catarrhalis (Μ. catarrhalis) Πανταχού Παρούσα πρωτεΐνη Α2 επιφανείας (UspA2). Πιο ιδιαίτερα, η παρούσα δήλωση αφορά σε UspA2 πρωτεΐνης κατασκευάσματα και ανοσογονικές συνθέσεις που περιλαμβάνουν τα κατασκευάσματα, εμβόλια που περιλαμβάνουν τέτοιες ανοσογονικές συνθέσεις και θεραπευτικές χρήσεις αυτών. Η εφεύρεση περαιτέρω αφορά σε συνθέσεις που περιλαμβάνουν UspA2 σε συνδυασμό με τουλάχιστον ένα αντιγόνο από Αιμόφιλο της Γρίπης, ανοσογονικές συνθέσεις που περιλαμβάνουν τα αντιγόνα, εμβόλια που περιλαμβάνουν τέτοιες ανοσογοντικές συνθέσεις και θεραπευτικές χρήσεις αυτών.
Patent CY-1124956-T1 (CY)
Title: Συριγγα
Inventor: ROYER CHRISTOPHE
IPC: A61K9/00
Filed: 2022-01-31
Abstract: Η παρούσα εφεύρεση αναφέρεται σε μια σύριγγα, συγκεκριμένα σε μια σύριγγα μικρού όγκου, όπως μια σύριγγα κατάλληλη για οφθαλμικές ενέσεις.
Patent HR-P20100659-T1 (HR)
Inventor: CARELL THOMAS
IPC: G01N33/53
Filed: 2010-11-30
Abstract: Postupak otkrivanja analita, izabranog izmedu nukleinskih kiselina, u uzorku, naznacen time sto obuhvaca korake: (i)	dobivanje uzorka; (ii)	dovodenje uzorka u doticaj s funkcionalnim spojem koji ima barem jednu funkcionalnu skupinu izabranu izmedu alkina i azida koji su prvi reakcijski partner za Clickovu reakciju, spomenuta Clickova reakcija je (3+2) cikloadicija izmedu azida i alkina koji tvore 1,2,3-triazolski prsten, i pri cemu je funkcionalna skupina spojena na nukleobazu nukleozidnog ili nukleotidnog spoja ili njegov oligomer ili polimer, pod uvjetima tako da spomenuti spoj tvori asocijacijski produkt s analitom koji se otkriva ili njegovim komplementom, (iii)	dovodenje asocijacijskog produkta u doticaj s drugim reakcijskim partnerom za spomenutu Clickovu reakciju s komplementarnom azidnom ili alkinom skupinom pod uvjetima gdje se odvija Clickova reakcija izmedu prvog i drugog reakcijskog partnera, pri cemu drugi reakcijski partner dalje obuhvaca marker ili prekursor markera,  (iv)	ako je potrebno, pretvaranje skupina prekursora markera u markere, iotkrivanje spomenutih markera. Patent sadrzi jos 77 patentnih zahtjeva.
Patent SI-1197223-T1 (SI)
Inventor: NAKAGAWA SHIZUE
IPC: A61K45/00
Filed: 2000-04-27
Abstract: To provide a pharmaceutical composition for preventing, treating or development-inhibiting simple retinopathy or preproliferative retinopathy, comprising a compound having angiotensin II antagonistic activity, or a salt thereof.
Patent SI-1515752-T1 (SI)
Title: Ace2 activation for treatment of heart, lung and kidney disease and hypertension
Inventor: PENNINGER JOSEPH M
IPC: C12N5/06
Filed: 2003-06-19
Abstract: The invention relates to an ACE2 genotyping kit comprising a detection agent for detecting the presence of an ACE2 polymorphism in a nucleic acid sample derived from an animal, preferably a human.
Patent SI-1565630-T1 (SI)
Title: Covering device
Inventor: BAUER AMBROS
IPC: E04H15/00
Filed: 2003-11-24
Abstract: The invention relates to a covering construction in a flexible device for covering heaped or stacked material, in particular for the aerobic treatment of organic-containing waste, for example residual waste or domestic refuse, in a compost heap. The covering construction has a cover which comprises a number of support elements which can be filled with at least one fluid and are connected to one another at least in part, and also at least one waterproof and gas-permeable sheet which is connected to the support elements. The device forms an erected state and a lowered state, depending on whether the support elements are filled or not. The sheet covers the material and undergoes a raising and lowering process via the filling and emptying of the support elements.
Patent SI-1551372-T1 (SI)
Title: Sequestering subunit and related compositions and methods
Inventor: BOEHM GARTH
IPC: A61K9/00
Filed: 2003-09-22
Abstract: A sequestering subunit comprising an aversive agent and a blocking agent, wherein the blocking agent substantially prevents release of the aversive agent from the sequestering subunit in the gastrointestinal tract for a time period that is greater than 24 hours; a composition comprising a sequestering subunit and a therapeutic agent in releasable form, wherein, optionally, the mechanical fragility of the sequestering subunit is the same as the mechanical fragility of the therapeutic agent in releasable form; a capsule or tablet comprising a sequestering subunit and a therapeutic agent; and a method of preventing abuse of a therapeutic agent.
Patent SI-1694292-T1 (SI)
Title: Therapeutic foam comprising a sclerosing solution and a low quanitiy of gaseous nitrogen
Inventor: WRIGHT DAVID DAKIN IORWERTH
IPC: A61K9/00
Filed: 2004-11-17
Abstract: A therapeutic foam for the treatment of, inter alia, varicose veins comprises a sclerosing solution foamed with a physiological gas such as carbon dioxide, oxygen or a mixture thereof. The foam has a nitrogen content of less than 0.8%. It may be generated using a pressurized canister system incorporating a fine mesh of micron dimensions through which the gas and sclerosing liquid are passed to make the foam. Alternatively, the foam may be generated by passing gas and solution between two syringes through a fine mesh. Techniques are described for minimizing the amount of nitrogen in a canister or syringe based product. A technique for generating and delivering foam simultaneously using a syringe based device is also disclosed.
Patent SI-1778623-T1 (SI)
Title: Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases
Inventor: RAVEGLIA LUCA
IPC: A61P25/00
Filed: 2005-07-26
Abstract: The present invention concerns novel derivatives of 1-phenylalkanecarboxylic acids, pharmaceutical compositions thereof, a process for their preparation and their use for the treatment and/or prevention of neurodegenerative diseases such as Alzheimer's disease.
Patent SI-1655145-T1 (SI)
Title: Printing plate for lacquers
Inventor: SCHLEUSSNER MARTIN
IPC: B41C1/00
Filed: 2005-11-04
Abstract: A pressure mold for a printing process, having a carrier layer and a hydrophilic lacquer transfer layer, also includes a filler layer of polyethylene, silicone, nitrile rubber, butyl rubber, polypropylene and/or PVC between the carrier and lacquer transferring layers. An independent claim is included for a method for producing the pressure mold, involving applying the filler layer to the carrier layer then applying the lacquer transfer layer.
Patent TR-200807385-T1 (TR)
Title: Su sağlama tertibatı
Inventor: BELFORD JAMES WALLEACE
IPC: E02B11/00
Filed: 2007-04-01
Abstract: Bir sulama borusuna su sağlamak üzere bir sulama kanalı ile birlikte kullanmak için uyarlanmış bir su sağlama tertibatı tarif edilmektedir. Söz konusu su sağlama tertibatı, suyu belirli bir seviyede tutacak şekilde uyarlanmış olan ve sulama borusu ile sıvı temasına gelmek için uyarlanmış bir ana çıkışı ihtiva eden bir ana rezervuarı ihtiva etmektedir. Sistem ayrıca suyu desteklemek üzere çekmek için söz konusu kanala manuel olarak 10 geçirilebilir bir proksimal uç, ve boruda emişi başlatmak için ve en azından emmenin başlatılmasından sonra söz konusu rezervuarda meyillenme için uyarlanmış olan bir distal uca sahip sifon borusu formunda en az bir ana giriş borusu ihtiva etmektedir.
Patent DE-3588037-T2 (DE)
Inventor: PEIGNEUR PAUL GUILLAUME LOUIS
IPC: C09J7/22
Filed: 1985-05-28
Granted: 1996-03-21
Abstract: A heat-recoverable wrap-around sleeve for pipe protection, with a patch-type closure.A patch is heat-stable and comprises two polymeric layers (4, 6) bonded together through, for example, an open mesh glass-fibre fabric (8). No separate adhesive is required.The hot modulus of one of the layers is low enough to enable it to bond to the overlapping edges of the wrap- around sleeve, and the hot modulus of the other layer is high enough to withstand installation temperature.This new patch is easier to install and requires less materials than prior art patches, and does not need to be bonded to the sleeve in such a distinct heating step.
Patent DE-3751824-T2 (DE)
Inventor: DESAGE ROBERT
IPC: H05B3/60
Filed: 1987-03-02
Granted: 1997-01-23
Abstract: To provide for the rapid vaporization of a liquid, a porous body is impregnated with the liquid. Then the liquid contained in the porous body is heated, so as to cause a rapid vaporization of the liquid in the porous body which liquid continually migrates through the porous body under the effect of its pumping and suction capabilities. The whole of the mass of liquid to be vaporized is stored in the body in impregnated form, without the presence of a permanent liquid layer. The liquid is heated directly by passing an electric current through the porous body, the density of the porous body being chosen so as to provide a liquid retention capacity allowing a variation of the energy dissipated in time to be obtained in accordance with a predetermined law which is a function of the density chosen for the porous body. Thus interchangeable porous bodies can be used having different densities and allowing different curves of variation of the energy dissipated in time to be obtained, respectively. To provide for operation in any position the liquid is introduced and stored in a liquid mass to be vaporized solely in impregnated form directly inside the porous body, without formation of a permanent liquid layer in a housing for the porous body.
Patent DE-3780778-T2 (DE)
Inventor: RASMUSSON GARY H
IPC: A61K31/435
Filed: 1987-11-11
Granted: 1993-01-14
Abstract: 17 beta -Acyl-4-aza-5 alpha -androst-1-en-3-ones of the formula: <CHEM> wherein R is selected from hydrogen, methyl and ethyl R<2> is methoxy, a monovalent radical selected from straight and branched chain alkyl of from 1-12 carbons, or monocyclic aryl optionally containing 1 or more lower alkyl substituents of from 1-2 carbon atoms and/or 1 or more halo (Cl or Br) substituents, aralkyl selected from benzyl and phenethyl and heterocyclic selected from 2- or 4-pyridyl, 2-pyrrolyl, 2-furyl or thiophenyl; and R', R'' and R''' are each selected from hydrogen and methyl and pharmaceutical formulations of the above compounds are active as testosterone 5 alpha -reductase inhibitors and thus are useful for treatment of acne, seborrhea, female hirsutism, and benign prostatic hypertrophy.
Patent DE-3876065-T2 (DE)
Inventor: O'CALLAGHAN WILFRID BERNARD
IPC: H01M50/77
Filed: 1988-09-22
Granted: 1993-04-15
Abstract: A metal-air battery is described having recirculated electrolyte. The battery comprises:     (a) a tank (10) defining a reservoir for liquid electrolyte, (b) a support panel (11) mounted in the tank above the electrolyte reservoir; (c) a plurality of individually removable metal-air cells (12) mounted in side-by-side relationship on said support panel (11) with air gaps therebetween, each cell comprising a pair of spaced-apart flat side walls (21) joined by end faces and top and bottom faces, said side walls including air cathodes (22), a metal anode (26) mounted between and spaced from said flat side walls, an electrolyte inlet connector below the lower edge of the anode and an electrolyte outlet connector, said connectors being adapted to removably extend through openings in said support panel, and said outlet connector being adapted to return electrolyte to the reservoir; and   (d) circuit means for connecting said cells to an external load. u
Patent TR-199801711-T2 (TR)
Inventor: VOGDANIS LAZAROS
IPC: C08G59/06
Filed: 1997-02-21
Abstract: Yukarida verilen bulus, a) organik bir çözüçü maddede, içinde R' in -Ph-D-Ph-(II)' in bir grubu ve bu sirada -Ph-' in bir fenilen ve D' in bir metilen- ya da propilen grubu oldugu HOROH (I) formülünün en azindan bir diyolünü (B) içeren maddede en azindan molekül basina 2 epoksid grubu olan en azindan bir epoksid reçineli (A) bir dispersiyon stabilizatörünün varliginda ve gerektiginde epoksid- ya da hidroksil gruplarina karsilik reaktif bir gruba sahip olan baska bir bilesen (C) ile yer degistirmesi ile meydana getirilebilen steril olarak stabilize edilmis, sulu-olmayan dispersiyon içeren bir kaplama maddesini ve b) en azindan birtane dallanma maddesi içerir.
Patent TR-199802252-T2 (TR)
Inventor: SANICOLA-NADEL MICHELE
IPC: A61K47/48
Filed: 1997-05-07
Abstract: This invention relates to nucleotide sequences which encode a Ret ligant (RetL9, as well as to methods of stimulating neural and renal growth by treating cells and mammalian subjects with RetL DNA or protein. The invention provides a purified and isolated DNA molecule coding for a RetL, having the nucleotide sequence of any RetL, but specifically including rat retL 1 cDNA (SEQ ID NO.1), partial human RetL1 cDNA (SEQ ID NO:8), full length human retL 1 cDNA (SEQ ID NO:10), human retL2 cDNA (SEQ ID NO:12), murine retL3 cDNA (SEQ ID NO:12) or human retL3 cDNA (SEQ ID NO;16), partial human retL3 cDNA (SEQ ID NO:18) or human retL3 cDNA (SEQ ID NO:20). The invention further provides a RetL protein, with an amino acid sequence comprising that of rat RetL1 (SEQ ID NO:2), partial human RetL1 (SEQ ID NO:9), full length human RetL (SEQ ID NO: 11), human RetL2 (SEQ ID NO:13), murine RetL3 (SEQ ID NO:17), partial human RetL3 (SEQ ID NO:19) or human RetL3 (SEQ ID NO:21).
Patent TR-199900761-T2 (TR)
Title: Reaksiyon gaz ve katilarini bir döküm firinina sürmek ve beslemek için bir metod ve söz konusu amaç için tasarlanmis çok çesitli ayarlanabilir bir yakici .
Inventor: HOLMI ISMO
IPC: C22B5/08
Filed: 1997-09-30
Abstract: Bu bulus, kontrollü ve ayarlanabilir bir süspansiyon yaratmak için bir süspansiyon döküm firininin reaksiyon saftina reaksiyon gaziyla ufalanmis katilar verilirken toz halindeki kati materyalinin dagitim havasi ve reaksiyon gazinin akis hizini ayarlamak için bir metot ile ilgilidir. Bu bulus ayrica bu metodu gerçeklestirmek için çok yönlü ayarlanabilir bir yakici ile de ilgilidir.